Breast Cancer Global Clinical Trials Review, Q4, 2010


#41780

100pages

GlobalData

$ 1000

In Stock


GlobalData's clinical trial report, “Breast Cancer Clinical Trials Review, Q4, 2010""” provides data on the Breast Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Breast Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Breast Cancer. 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

1 Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6

2 Introduction 7
2.1 Breast Cancer Overview 7
2.2 Report Guidance 7

3 Clinical Trials by Region 8
3.1 Clinical Trials by Country 9
3.1.1 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
3.1.2 Top Five Countries Contributing to Clinical Trials in Europe 12
3.1.3 Top Countries Contributing to Clinical Trials in North America 13
3.1.4 Top Countries Contributing to Clinical Trials in Central and South America 14
3.2 Clinical Trials by BRIC Countries 15

4 Clinical Trials by Phase 16
4.1 In Progress Trials by Phase 17

5 Clinical Trials by Trial Status 18
5.1 Unaccomplished Trials of Breast Cancer 19

6 Subjects Recruited Over a Period of Time 21

7 Prominent Sponsors 22

7.1 Top 10 Companies Participating in Breast Cancer Clinical Trials 23

8 Prominant Drug Comparison 24

9 Clinical Trial Profiles 25

9.1 Clinical Trial Overview of the Top 20 Companies 25
9.1.1 Pfizer, Inc. 25
9.1.2 AstraZeneca PLC 28
9.1.3 Novartis Pharmaceuticals Corporation 31
9.1.4 GlaxoSmithKline plc 32
9.1.5 Sanofi-Aventis 35
9.1.6 Johnson & Johnson 36
9.1.7 Bristol-Myers Squibb Company 37
9.1.8 Eli Lilly and Company 39
9.1.9 Abbott Laboratories 41
9.1.10 Hoffmann-La Roche Ltd., 41
9.1.11 Celgene Corporation 44
9.1.12 Daiichi Sankyo Company, Ltd. 44
9.1.13 Bayer AG 45
9.1.14 Eisai Inc. 46
9.1.15 GE Healthcare 47
9.1.16 Biogen Idec Inc. 47
9.1.17 Copharos Inc. 48
9.2 Clinical Trial Overview by Top 20 Universities / Institutes / Hospitals 48
9.2.1 National Cancer Center 48
9.2.2 The University of Texas M. D. Anderson Cancer Center 62
9.2.3 Vanderbilt Medical Center 67
9.2.4 Memorial Sloan Kettering Cancer Center 67
9.2.5 North Central Cancer Group 72
9.2.6 Cancer Research UK 75
9.2.7 Robert H. Lurie Comprehensive Cancer Center of Northwestern University 77
9.2.8 Fred Hutchinson Cancer Research Center 78
9.2.9 European Organization for Research and Treatment of Cancer 79
9.2.10 Dana-Farber Cancer Institute 81
9.2.11 The Cancer and Leukemia Group B 83
9.2.12 Columbia University 85
9.2.13 UCLA's Jonsson Comprehensive Cancer Center 86
9.2.14 Case Comprehensive Cancer Center 87
9.2.15 Mayo Clinic 89
9.2.16 Duke University 91
9.2.17 Ohio State University 92
9.2.18 Southwest Oncology Group 93
9.2.19 National Cancer Center 95
9.2.20 University of Pennsylvania 96

10 Appendix 97
10.1 Abbreviations 97
10.2 Definitions 97
10.3 Research Methodology 98
10.4 Secondary Research 99
10.5 About GlobalData 99
10.6 Contact Us 99
10.7 Disclaimer 100
10.8 Source 100


Table 1: Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 8
Table 2: Breast Cancer Therapeutics Clinical Trials and in Progress Trials Market, Global, by Top Countries, 2010* 10
Table 3: Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010* 11
Table 4: Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 12
Table 5: Breast Cancer Therapeutics Clinical Trials, North America, Top Countries, 2010* 13
Table 6: Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2010* 14
Table 7: Breast Cancer Therapeutics Clinical Trials, BRIC Countries, 2010* 15
Table 8: Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 16
Table 9: Breast Cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 17
Table 10: Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 18
Table 11: Breast Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2010* 19
Table 12: Breast Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2010* 19
Table 13: Breast Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2010* 20
Table 14: Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21
Table 15: Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 22
Table 16: Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 23
Table 17: Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010* 24
Table 18: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2010* 25
Table 19: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Astra Zeneca PLC, 2010* 28
Table 20: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2010* 31
Table 21: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2010* 32
Table 22: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2010* 35
Table 23: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2010* 36
Table 24: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2010* 37
Table 25: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2010* 39
Table 26: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2010* 41
Table 27: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Ltd., 2010* 41
Table 28: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2010* 44
Table 29: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Ltd., 2010* 44
Table 30: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2010* 45
Table 31: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2010* 46
Table 32: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GE Healthcare, 2010* 47
Table 33: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc, 2010* 47
Table 34: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Copharos Inc , 2010* 48
Table 35: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2010* 48
Table 36: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2010* 62
Table 37: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt Medical Center, 2010* 67
Table 38: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2010* 67
Table 39: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Group , 2010* 72
Table 40: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2010* 75
Table 41: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2010* 77
Table 42: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2010* 78
Table 43: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2010* 79
Table 44: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute , 2010* 81
Table 45: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cancer and Leukemia Group B, 2010* 83
Table 46: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2010* 85
Table 47: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA\'s Jonsson Comprehensive Cancer Center, 2010* 86
Table 48: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2010* 87
Table 49: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2010* 89
Table 50: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2010* 91
Table 51: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University, 2010* 92
Table 52: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2010* 93
Table 53: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2010* 95
Table 54: Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2010* 96


Figure 1: Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 8
Figure 2: Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 9
Figure 3: Breast Cancer Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2010* 10
Figure 4: Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010* 11
Figure 5: Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 12
Figure 6: Breast Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2010* 13
Figure 7: Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2010* 14
Figure 8: Breast Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2010* 15
Figure 9: Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 16
Figure 10: Breast Cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 17
Figure 11: Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 18
Figure 12: Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 21
Figure 13: Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 22
Figure 14: Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 23
Figure 15: Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010* 24
Figure 16: GlobalData Methodology 98